Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis
Open Access
- 11 December 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 9 (12), e1936
- https://doi.org/10.7759/cureus.1936
Abstract
Erythroderma is characterized by erythema involving greater than 90% of the body surface area and may be caused by several etiologies, including erythrodermic psoriasis. Psoriasis is an autoimmune skin and systemic condition characterized by erythematous and scaly plaques. Monoclonal B-cell lymphocytosis is an asymptomatic hematological disorder diagnosed by elevated, small, clonal B-cell counts in the peripheral blood. The characteristics of a 71-year-old man with new onset of erythrodermic psoriasis and concurrent monoclonal B-cell lymphocytosis are presented. The simultaneous development of these two conditions raises the possibility that they may share a related pathogenesis.Keywords
This publication has 10 references indexed in Scilit:
- Interleukin 23–Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra PilarisJAMA Dermatology, 2017
- The role of histological presentation in erythrodermaInternational Journal of Dermatology, 2017
- Erythrodermic psoriasis: pathophysiology and current treatment perspectivesPsoriasis: Targets and Therapy, 2016
- What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challengesSeminars in Oncology, 2016
- PsoriasisThe Lancet, 2015
- Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratificationBlood, 2015
- A Review of the Diagnosis and Management of Erythroderma (Generalized Red Skin)Advances in Skin & Wound Care, 2015
- Pityriasis Rubra PilarisAmerican Journal of Clinical Dermatology, 2010
- Pustular and Erythrodermic PsoriasisDermatologic Clinics, 1995
- Pityriasis rubra pilaris: A review of diagnosis and treatmentJournal of the American Academy of Dermatology, 1989